Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

A sharp AMP rally and surge in trading volume have driven attention, with traders debating whether the move signals a sustained breakout or another short-lived pump. Some bullish holders point to Flexas reported European expansion and broader crypto-payments adoption, while skeptics remain focused on AMPs steep long-term losses and lack of demonstrated token demand.

Quants rally is being tied by traders to a reported partnership with The Clearing House to support tokenized deposits across major U.S. banks, reinforcing its interoperability-for-finance narrative. Bulls point to the limited token supply and rising volume as potential fuel, while some question whether institutional adoption will translate into value for the token and warn of a sharp pullback.

The token is drawing attention through community promotion of its tokenized 401(k) and early-retirement meme-coin narrative, alongside calls for recurring DCA and celebration of price rallies and trending status. Bullish holders frame it as a community-backed long-term play, while critics and some holders point to volatility, selling pressure, and concerns about its speculative nature.

Jobys Texas eIPP flight demonstrations and autonomous cross-country flight are drawing attention as milestones toward commercial operations and FAA certification. Bulls see progress toward launch, while bears point to the stocks steep decline, cash burn and dilution concerns, noting that eIPP flights are not yet commercial passenger service.

Anticipation of LUNC supply burns and Terra Classic ecosystem changesincluding the proposed Market Module 2.0 and a possible USTC repegis driving discussion, alongside reports of ongoing Binance burns and new DO Chain activity. Bulls expect these developments to support a comeback, while skeptics question whether burns can meaningfully offset the large supply and point to weak trading and recurring price declines.

FDA approval of RASONQUE (daraxonrasib) for metastatic pancreatic cancer, backed by positive Phase 3 results, is the dominant focus. Traders are weighing the drugs commercial potential and analyst optimism against a muted post-approval share reaction and questions about pricing, uptake, and valuation.

AVT is drawing attention after Aventus disclosed that an attacker exploited a code vulnerability to mint tokens and sell them into the market, with the project attributing a sharp selloff to that selling. Traders are debating a rebound or liquidity squeeze in the thinly traded token, while others remain concerned about continued selling, token-supply changes, and weak liquidity.

CHIP is drawing attention for USD.AIs AI-infrastructure thesis: using GPU-backed lending to finance compute, with traders pointing to reported loan activity and ecosystem growth. The bullish case is contested by frustration over the tokens sharp decline, volatility, and alleged selling or future supply pressure, alongside speculation about a rebound.

SHIBs price rebound and attempted move through resistance have sparked hopes of a renewed meme-coin rally, with bullish traders calling for more gains and accumulating. Skeptics counter that the token remains stagnant and question its utility, large supply, and limited burn impact.

DOG is drawing attention around its volatile price action and hopes for a recovery alongside Bitcoin. Bulls tout it as a community-driven, Bitcoin-native meme asset and say they are buying the dip, while skeptics point to thin liquidity, continued weakness, and manipulation concerns.